A Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: Big Ten Cancer Research Consortium (BTCRC)- LUN 17-139-Reference-Cited by-同舟云学术

A Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: Big Ten Cancer Research Consortium (BTCRC)- LUN 17-139

Published:2022-11 Issue:7 Volume:23 Page:578-584
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Ardeshir-Larijani Fatemeh^ORCID,Althouse Sandra K.,Leal Ticiana,Feldman Lawrence Eric,Hejleh Taher Abu,Patel Malini,Gentzler Ryan D.,Miller Adam Ryan,Hanna Nasser H

Funder

Genentech

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer;Sandler;N Engl J Med,2006

2. Risk of Adverse Vascular Events in Newly Diagnosed Glioblastoma Multiforme Patients Treated with Bevacizumab: a Systematic Review and Meta-Analysis;Li;Sci Rep,2015

3. Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics;Hegde;Semin Cancer Biol,2018

4. Combinations of bevacizumab with cancer immunotherapy;Chen;The Cancer Journal,2018

5. Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma;Motzer;JAMA Oncol,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research advances in mechanism of antiangiogenic therapy combined with immune checkpoint inhibitors for treatment of non-small cell lung cancer;Frontiers in Immunology;2023-10-16